Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
- DOI
- 10.1007/s40744-024-00708-8
- Published
- 2024-08-31
- Container
- Rheumatology and Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40744-024-00708-8,
title = {Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies},
author = {Philip J. Mease and Joseph F. Merola and Yoshiya Tanaka and Laure Gossec and Iain B. McInnes and Christopher T. Ritchlin and Robert B. M. Landewé and Akihiko Asahina and Barbara Ink and Andrea Heinrichs and Rajan Bajracharya and Vishvesh Shende and Jason Coarse and Laura C. Coates},
year = {2024},
journal = {Rheumatology and Therapy},
doi = {10.1007/s40744-024-00708-8},
url = {https://doi.org/10.1007/s40744-024-00708-8}
}RIS
TY - JOUR TI - Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies AU - Philip J. Mease AU - Joseph F. Merola AU - Yoshiya Tanaka AU - Laure Gossec AU - Iain B. McInnes AU - Christopher T. Ritchlin AU - Robert B. M. Landewé AU - Akihiko Asahina AU - Barbara Ink AU - Andrea Heinrichs AU - Rajan Bajracharya AU - Vishvesh Shende AU - Jason Coarse AU - Laura C. Coates PY - 2024 JO - Rheumatology and Therapy DO - 10.1007/s40744-024-00708-8 UR - https://doi.org/10.1007/s40744-024-00708-8 ER -
APA
Mease, P. J., Merola, J. F., Tanaka, Y., Gossec, L., McInnes, I. B., Ritchlin, C. T., Landewé, R. B. M., Asahina, A., Ink, B., Heinrichs, A., Bajracharya, R., Shende, V., Coarse, J., & Coates, L. C. (2024). Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies. Rheumatology and Therapy. https://doi.org/10.1007/s40744-024-00708-8
Source records
- crossref · retrieved 2026-09-26T07:54:27.494Z